Geron Corporation (GERN)
NASDAQ: GERN · Real-Time Price · USD
0.9685
-0.1815 (-15.78%)
At close: Oct 28, 2026, 4:00 PM EDT
0.9800
+0.0115 (1.19%)
Pre-market: Oct 29, 2026, 5:01 AM EDT

Geron Revenue

Geron had revenue of $57.48M in the quarter ending June 30, 2026, with 17.22% growth. This brings the company's total for the last twelve months to $204.56M, up 24.39% year-over-year. In the year 2025, Geron had annual revenue of $183.88M with 138.83% growth. That makes Geron the 17,327th largest company in the world by revenue and 2,868th in the United States.

Revenue (ttm)
$204.56M
Revenue Growth
+24.39%
P/S Ratio
3.04
Revenue / Employee
$792,864
Employees
258
Market Cap
622.24M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025183.88M106.89M138.83%
Dec 31, 202476.99M76.76M32,386.92%
Dec 31, 2023237.00K-359.00K-60.23%
Dec 31, 2022596.00K-797.00K-57.21%
Dec 31, 20211.39M1.14M450.59%
Dec 31, 2020253.00K-207.00K-45.00%
Dec 31, 2019460.00K-606.00K-56.85%
Dec 31, 20181.07M1.00K0.09%
Dec 31, 20171.07M-5.10M-82.72%
Dec 31, 20166.16M-30.21M-83.06%
Dec 31, 201536.37M35.22M3,054.47%
Dec 31, 20141.15M-130.00K-10.13%
Dec 31, 20131.28M-1.43M-52.64%
Dec 31, 20122.71M271.00K11.12%
Dec 31, 20112.44M-1.13M-31.57%
Dec 31, 20103.56M1.84M106.43%
Dec 31, 20091.73M-1.08M-38.42%
Dec 31, 20082.80M-4.82M-63.22%
Dec 31, 20077.62M4.35M132.59%
Dec 31, 20063.28M-2.88M-46.78%
Dec 31, 20056.16M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Ardelyx450.89M
Ginkgo Bioworks Holdings132.42M
Apnimed115.12M
Iambic Therapeutics18.25M
Adlai Nortye Group18.06M
Revenue Rankings